ProPhase Labs, Inc. (PRPH)
NASDAQ: PRPH · Real-Time Price · USD
0.530
-0.079 (-12.97%)
Jan 22, 2025, 3:47 PM EST - Market open

ProPhase Labs Market Cap

ProPhase Labs has a market cap or net worth of $12.65 million as of January 22, 2025. Its market cap has decreased by -85.49% in one year.

Market Cap
12.65M
Enterprise Value
41.26M
1-Year Change
-85.49%
Ranking
Category
Stock Price
$0.53

Market Cap Chart

Since December 1, 1998, ProPhase Labs's market cap has decreased from $92.00M to $12.65M, a decrease of -86.25%. That is a compound annual growth rate of -7.30%.

History

DateMarket Cap% Change
Jan 21, 202514.50M-19.89%
Dec 31, 202418.10M-77.82%
Dec 29, 202381.60M-47.96%
Dec 30, 2022156.80M41.01%
Dec 31, 2021111.20M4.41%
Dec 31, 2020106.50M367.11%
Dec 31, 201922.80M-37.36%
Dec 31, 201836.40M34.81%
Dec 29, 201727.00M-21.05%
Dec 30, 201634.20M33.59%
Dec 31, 201525.60M13.27%
Dec 31, 201422.60M-11.72%
Dec 31, 201325.60M26.73%
Dec 31, 201220.20M19.53%
Dec 30, 201116.90M-3.98%
Dec 31, 201017.60M-30.98%
Dec 31, 200925.50M-50.58%
Dec 31, 200851.60M-15.69%
Dec 31, 200761.20M-15.24%
Dec 29, 200672.20M-55.24%
Dec 30, 2005161.30M64.42%
Dec 31, 200498.10M-19.85%
Dec 31, 2003122.40M94.29%
Dec 31, 200263.00M156.10%
Dec 31, 200124.60M179.55%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 653.46B
UnitedHealth Group 469.12B
Johnson & Johnson 353.99B
Novo Nordisk 352.70B
AbbVie 303.17B
Merck & Co. 247.70B
Thermo Fisher Scientific 214.07B
Intuitive Surgical 211.09B
Market Cap Rankings